Schedule 13G ownership disclosure

ORIC Pharmaceuticals Inc

Security class unavailable · CUSIP: 68622P109

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,904,096
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-006454
Form type
SC 13G/A
Filer
ALKEON CAPITAL MANAGEMENT LLC
CIK
CIK 1230239
Filed
Nov 13, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub